X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Procter & Gamble Health with Natco Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PROCTER & GAMBLE HEALTH vs NATCO PHARMA - Comparison Results

PROCTER & GAMBLE HEALTH     Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PROCTER & GAMBLE HEALTH NATCO PHARMA PROCTER & GAMBLE HEALTH/
NATCO PHARMA
 
P/E (TTM) x 63.5 13.4 474.7% View Chart
P/BV x 11.1 2.8 397.2% View Chart
Dividend Yield % 0.3 1.6 19.2%  

Financials

 PROCTER & GAMBLE HEALTH   NATCO PHARMA
EQUITY SHARE DATA
    PROCTER & GAMBLE HEALTH
Dec-17
NATCO PHARMA
Mar-18
PROCTER & GAMBLE HEALTH/
NATCO PHARMA
5-Yr Chart
Click to enlarge
High Rs1,3581,080 125.7%   
Low Rs933671 139.0%   
Sales per share (Unadj.) Rs665.0592.1 112.3%  
Earnings per share (Unadj.) Rs56.6188.4 30.0%  
Cash flow per share (Unadj.) Rs72.5206.3 35.1%  
Dividends per share (Unadj.) Rs15.008.25 181.8%  
Dividend yield (eoy) %1.30.9 139.0%  
Book value per share (Unadj.) Rs441.7833.6 53.0%  
Shares outstanding (eoy) m16.6036.90 45.0%   
Bonus/Rights/Conversions -IS-  
Price / Sales ratio x1.71.5 116.4%   
Avg P/E ratio x20.24.6 435.6%  
P/CF ratio (eoy) x15.84.2 372.4%  
Price / Book Value ratio x2.61.1 246.8%  
Dividend payout %26.54.4 605.5%   
Avg Mkt Cap Rs m19,01132,311 58.8%   
No. of employees `0001.54.8 32.0%   
Total wages/salary Rs m1,6963,256 52.1%   
Avg. sales/employee Rs Th7,150.04,522.5 158.1%   
Avg. wages/employee Rs Th1,098.7674.0 163.0%   
Avg. net profit/employee Rs Th608.21,439.0 42.3%   
INCOME DATA
Net Sales Rs m11,04021,848 50.5%  
Other income Rs m240404 59.3%   
Total revenues Rs m11,27922,252 50.7%   
Gross profit Rs m1,3769,284 14.8%  
Depreciation Rs m264662 39.9%   
Interest Rs m0154 0.0%   
Profit before tax Rs m1,3528,872 15.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m1700-   
Tax Rs m5831,920 30.4%   
Profit after tax Rs m9396,952 13.5%  
Gross profit margin %12.542.5 29.3%  
Effective tax rate %43.121.6 199.2%   
Net profit margin %8.531.8 26.7%  
BALANCE SHEET DATA
Current assets Rs m7,52321,307 35.3%   
Current liabilities Rs m2,2535,920 38.1%   
Net working cap to sales %47.770.4 67.8%  
Current ratio x3.33.6 92.8%  
Inventory Days Days5273 71.2%  
Debtors Days Days41107 38.1%  
Net fixed assets Rs m1,24014,986 8.3%   
Share capital Rs m166369 45.0%   
"Free" reserves Rs m7,16730,353 23.6%   
Net worth Rs m7,33330,760 23.8%   
Long term debt Rs m00-   
Total assets Rs m9,91237,151 26.7%  
Interest coverage xNM58.6-  
Debt to equity ratio x00-  
Sales to assets ratio x1.10.6 189.4%   
Return on assets %9.519.1 49.5%  
Return on equity %12.822.6 56.7%  
Return on capital %20.829.3 70.7%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m1,01510,322 9.8%   
Fx outflow Rs m3,0432,978 102.2%   
Net fx Rs m-2,0287,343 -27.6%   
CASH FLOW
From Operations Rs m5374,636 11.6%  
From Investments Rs m-476-11,155 4.3%  
From Financial Activity Rs m-2206,509 -3.4%  
Net Cashflow Rs m-160-18 886.1%  

Share Holding

Indian Promoters % 0.0 52.0 -  
Foreign collaborators % 51.8 1.5 3,523.8%  
Indian inst/Mut Fund % 18.2 7.8 232.1%  
FIIs % 1.0 16.6 6.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 26.0 111.9%  
Shareholders   28,591 25,395 112.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PROCTER & GAMBLE HEALTH With:   JUBILANT LIFE SCIENCES  PANACEA BIOTECH  CADILA HEALTHCARE  GSK PHARMA  PLETHICO PHARMA  

Compare PROCTER & GAMBLE HEALTH With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices End on a Positive Note for Third Straight Day; Yes Bank Falls 5%(Closing)

Indian share markets traded on a positive note most of the day and ended marginally higher. Sectoral indices ended on a mixed note with stocks in the IT sector.

Related Views on News

PROCTER & GAMBLE HEALTH at All Time High; BSE HEALTHCARE Index Up 0.1% (Market Updates)

Jul 17, 2019 | Updated on Jul 17, 2019

PROCTER & GAMBLE HEALTH share price has hit an all time high at Rs 4,995 (up 4.4%). The BSE HEALTHCARE Index is up by 0.1%. Among the top gainers in the BSE HEALTHCARE Index today are PROCTER & GAMBLE HEALTH (up 4.4%) and SANOFI INDIA . The top losers include THYROCARE TECHNOLOGIES (down 0.2%) and CIPLA (down 0.2%).

PROCTER & GAMBLE HEALTH at All Time High; BSE HEALTHCARE Index Down 0.4% (Market Updates)

Jul 17, 2019 | Updated on Jul 17, 2019

PROCTER & GAMBLE HEALTH share price has hit an all time high at Rs 4,774 (up 1.4%). The BSE HEALTHCARE Index is down by 0.4%. Among the top gainers in the BSE HEALTHCARE Index today are PROCTER & GAMBLE HEALTH (up 1.4%) and ABBOTT INDIA (up 0.9%). The top losers include FORTIS HEALTHCARE (down 0.1%) and CADILA HEALTHCARE (down 0.1%).

NATCO PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 59.8% (Quarterly Result Update)

May 28, 2019 | Updated on May 28, 2019

For the quarter ended March 2019, NATCO PHARMA has posted a net profit of Rs 1 bn (down 59.8% YoY). Sales on the other hand came in at Rs 5 bn (down 40.6% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

MERCK Announces Quarterly Results (4QFY19); Net Profit Up 79.2% (Quarterly Result Update)

May 13, 2019 | Updated on May 13, 2019

For the quarter ended March 2019, MERCK has posted a net profit of Rs 407 m (up 79.2% YoY). Sales on the other hand came in at Rs 2 bn (down 23.3% YoY). Read on for a complete analysis of MERCK's quarterly results.

MERCK LTD Announces Quarterly Results (3QFY19); Net Profit Up 31.3% (Quarterly Result Update)

Mar 5, 2019 | Updated on Mar 5, 2019

For the quarter ended December 2018, MERCK LTD has posted a net profit of Rs 135 m (up 31.3% YoY). Sales on the other hand came in at Rs 2 bn (down 32.8% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

More Views on News

Most Popular

These 3 Smallcap Stocks are Set to Make the Most of Smallcap Rebound(Profit Hunter)

Jul 9, 2019

As the sense of normalcy returns to the markets, the rebound in the quality smallcaps could be huge.

2 Stocks from Super Investor Sanjay Bakshi's Portfolio You Can Bet On...(The 5 Minute Wrapup)

Jul 12, 2019

Despite the current fear prevailing in the markets, both these stocks have the potential to deliver in 4-5 years.

A One Stock Crorepati(Profit Hunter)

Jul 4, 2019

Do you wish you could become a crorepati in the stock market? Read on...

After Disappointing Budget, Here's a Document that Concerns Largecap and Smallcap Investors(The 5 Minute Wrapup)

Jul 8, 2019

A new 'definition' of the stock universe that triggered the smallcap sell-off is back with the latest list...

Union Budget 2019-2020: More Style Over Substance(The 5 Minute Wrapup)

Jul 5, 2019

Did the Union Budget announce measures to stimulate the economy and bolster corporate earnings growth?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PROCTER & GAMBLE HEALTH SHARE PRICE


Jul 17, 2019 (Close)

TRACK PROCTER & GAMBLE HEALTH

  • Track your investment in PROCTER & GAMBLE HEALTH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PROCTER & GAMBLE HEALTH

PROCTER & GAMBLE HEALTH 8-QTR ANALYSIS

COMPARE PROCTER & GAMBLE HEALTH WITH

MARKET STATS